| Bioactivity | BTK-IN-11 is a potent inhibitor of BTK. BTK plays an important role in signaling mediated by B cell antigen receptor (BCR) and Fcγreceptor (FcγR) in B cells and myeloid cells, respectively. BTK-IN-11 has the potential for the research of related diseases, especially autoimmune diseases, inflammatory diseases or cancer (extracted from patent WO2022063101A1, compound Z2)[1]. |
| Name | BTK-IN-11 |
| CAS | 2765852-46-6 |
| Formula | C26H22ClN5O3 |
| Molar Mass | 487.94 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Fusheng Zhou, et al. Aroyl substituted tricyclic compound, preparation method therefor and use thereof. Patent WO2022063101A1. |
BTK-IN-11
CAS: 2765852-46-6 F: C26H22ClN5O3 W: 487.94
BTK-IN-11 is a potent inhibitor of BTK. BTK plays an important role in signaling mediated by B cell antigen receptor (BC
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.